Anesthetic considerations for bariatric surgery

Anesthesia and Analgesia

Volumn 95, Issue 6, 2002, Pages 1793-1805

  Ogunnaike, Babatunde O ^a   Jones, Stephanie B ^a   Jones, Daniel B ^b   Provost, David ^b   Whitten, Charles W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CISATRACURIUM; DIGOXIN; FENTANYL; MIDAZOLAM; PROCAINAMIDE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SUFENTANIL; SUXAMETHONIUM; THIOPENTAL; VECURONIUM;

EPIDURAL ANESTHESIA; GENERAL ANESTHESIA; HUMAN; INTUBATION; LAPAROSCOPY; OBESITY; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE;

EID: 0036894450     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200212000-00061     Document Type: Review

References (137)

1. NIH conference: Gastrointestinal surgery for severe obesity - Consensus Development Conference Panel. Ann Intern Med 1991;115:956-61.
2. Bray GA. Pathophysiology of obesity. Am J Clin Nutr 1992; 55(Suppl):488-94.
3. Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States 1991-1998. JAMA 1999; 282:1519-22.
4. Quetelet LAJ. A treatise on man and the development of his faculties: Edinburgh 1842, reprinted. Obes Res 1994;2:72-85.
5. Wing RR, Koeske R, Epstein LH, et al. Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 1987;147:1749-53.
6. Stevens V, Corrigan S, Obarzanek E, et al. Weight loss intervention in phase I of the trials of hypertension prevention. Arch Intern Med 1993;153:849-58.
7. Dattilo A, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: A meta-analysis. Am J Clin Nutr 1992;56:320-8.
8. Provost DA, Jones DB. Minimally invasive surgery for the treatment of severe obesity. Dallas Med J 1999;87:110-3.
9. Balsiger BM, Murr MM, Poggio JL, Sarr MG. Bariatric surgery: Surgery for weight control in patients with morbid obesity. Med Clin North Am 2000;84:477-89.
10. Scott DJ, Provost DA, Jones DB. Laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surg Rounds 2000;23:177-89.
11. Wittgrove AC, Clark GW, Schubert KR. Laparoscopic gastric bypass, Roux-en-Y: Technique and results in 75 patients with 3-30 months of follow-up. Obes Surg 1996;6:500-4.
12. Schirmer BD. Laparoscopic bariatric surgery. Surg Clin North Am 2000;80:1253-67.
13. Sugerman HJ, Kellum JM, Engle KM, et al. Gastric bypass for treating severe obesity. Am J Clin Nutr 1992;55(Suppl):560-6.
14. Long SD, O'Brien K, Macdonald KG Jr, et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. Diabetes Care 1994;17:372-5.
15. Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open bypass: A randomized study of outcomes, quality of life, and costs. Ann Surg 2001;234:279-91.
16. Wittgrove AC, Clark GW. Laparoscopic bypass, Roux-en-Y: 500 patients - Technique and results, with 3-60 month follow-up. Obes Surg 2000;10:233-9.
17. Capella JF, Capella RF. The weight reduction operation of choice: Vertical banded gastroplasty or gastric bypass? Am J Surg 1996;171:74-9.
18. Hasler WL. Dumping syndrome. Curr Treat Options Gastroenterol 2002;5:139-45.
19. Vecht J, Masclee AA, Lamers CB. The dumping syndrome: Current insights into pathophysiology, diagnosis, and treatment. Scand J Gastroenterol 1997;223(Suppl):21-7.
20. Belachew M, Legrand M, Vincent V, et al. Laparoscopic adjustable silicone gastric banding in the treatment of morbid obesity: A preliminary report. Surg Endosc 1994;8:1354-6.
21. Kunath U, Susewind M, Klein S, Hofmann T. Success and failure in laparoscopic gastric banding: A report of 3 years experience. Chirurg 1998;69:180-5.
22. Westling A, Bjurling K, Ohrvall M, Gustavsson S. Silicone-adjustable gastric banding: Disappointing results. Obes Surg 1998;8:467-74.
23. Forsell P, Hallerback B, Glise H, Hellers G. Complications following Swedish adjustable gastric banding: A long-term follow-up. Obes Surg 1999;9:11-6.
24. Nehoda H, Weiss H, Labeck B, et al. Results and complications after adjustable gastric banding in a series of 250 patients. Am J Surg 2001;181:12-5.
25. Heal DJ, Aspley S, Prow MR, et al. Sibutramine: A novel anti-obesity drug - A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int J Obes Relat Metab Disord 1998;22(Suppl):18-28.
26. Garattini S, Mennini T, Bendotti C, et al. Neurochemical mechanism of action of drugs which modify feeding via the serotonergic system. Appetite 1986;7(Suppl):15-38.
27. Rich JM, Njo L, Roberts KW, Smith P. Unusual hypotension and bradycardia in a patient receiving fenfluramine, phentermine, and fluoxetine. Anesthesiology 1997;88:529-31.
28. McNeely W, Goa KL. Sibutramine: A review of its contribution to the management of obesity. Drugs 1998;56:1093-124.
29. Bray GA, Greenway FL. Current and potential drugs for treatment of obesity. Endocr Rev 1999;20:805-75.
30. McMahon F, Fujioka K, Singh B, et al. Efficacy and safety of sibutramine in obese white and African-American patients with hypertension: A one-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med 2000;160:2185-91.
31. Apfelbaum M, Vague P, Ziegler O, et al. Long-term maintenance of weight loss after a very low-calorie diet: A randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med 1999;106:179-84.
32. Hadvary P, Lengsfeld H, Wolfer H. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipostatin. Biochem J 2000;256:357-61.
33. Davidson M, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. JAMA 1999;281:235-42.
34. Hauptman J, Lucas C, Boldrin M, et al. Long-term treatment of obesity in primary care settings. Arch Fam Med 2000;9:160-7.
35. Sjöström L, Rissanen A, Andersen T, et al. Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998;352:167-72.
36. Valsecia ME, Malgor LA, Farias EF, et al. Interaction between orlistat and antihypertensive drugs. Ann Pharmacother 2001; 35:1495-6.
37. Persson M, Vitols S, Yue QY. Orlistat associated with hypertension. BMJ 2000;321:87.
38. Johnston GD. Orlistat associated with hypertension: Digit preference lays conclusions about orlistat open to doubt [letter]. BMJ 2001;322:110.
39. Gotfredsen A, Westergren-Hendel H, Andersen T. Influence of orlistat on bone turnover and body composition. Int J Obes Relat Metab Disord 2001;25:1154-60.
40. Scheen AJ. Results of obesity treatment. Ann Endocrinol 2002; 63:163-70.
41. Clain DJ, Lefkowitch JH. Fatty liver disease in morbid obesity. Gastroenterol Clin North Am 1987;16:239-52.
42. Ramsey-Stewart G. Hepatic steatosis and morbid obesity. Obes Surg 1993;3:157-9.
43. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology 1990; 99:1408-13.
44. Albert S, Borovicka J, Thurnheer M, et al. Pre- and post-operative transaminase changes within the scope of gastric banding in morbid obesity. Schweiz Rundsch Med Prax 2001; 90:1459-64.
45. Gholam PM, Kotler DP, Flancbaum LJ. Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Obes Surg 2002;12:49-51.
46. Cheymol G. Effects of obesity on pharmacokinetics: Implications for drug therapy. Clin Pharmacokinet 2000;39:215-31.
47. Marik P, Varon J. The obese patient in the ICU. Chest 1998; 113:492-8.
48. Ribstein J, duCailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 1995;26:610-5.
49. Brochner-Mortensen J, Rickers H, Balslev I. Renal function and body composition before and after intestinal bypass operation in obese patients. Scand J Clin Lab Invest 1980;40:695-702.
50. Brenner BM. Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983; 23:647-55.
51. Davis RL, Quenzer RW, Bozigian HP, Warner CW. Pharmacokinetics of ranitidine in morbidly obese women. DICP 1990;24:1040-3.
52. Stokholm KH, Brochner-Mortensen J, Hoilund-Carlsen PF. Increased glomerular filtration rate and adrenocortical function in obese women. Int J Obes 1980;4:57-63.
53. Dionne RE, Bauer LA, Gibson GA, et al. Estimating creatinine clearance in morbidly obese patients. Am J Hosp Pharm 1981; 38:841-4.
54. Nauser TD, Stites SW. Diagnosis and treatment of pulmonary hypertension. Am Fam Physician 2001;63:1789-98.
55. Schiller NB. Pulmonary artery pressure estimation by Doppler and two-dimensional echocardiography. Cardiol Clin 1990;8:277-87.
56. Widimsky J. Noninvasive diagnosis of pulmonary hypertension in chronic lung diseases. Prog Respir Res 1985;20:69-75.
57. Konduri GG, Garcia DC, Kazzi NJ, et al. Adenosine infusion improves oxygenation in term infants with respiratory failure. Pediatrics 1996;97:295-300.
58. Stoelting RK, Dierdorf SF. Anesthesia and Co-Existing Disease. 4th Ed. Philadelphia: Churchill Livingstone, 2002.
59. Consensus conference: Fresh-frozen plasma - Indications and risks. JAMA 1985;253:551-3.
60. Derzie AJ, Silvestri F, Liriano E, Benotti P. Wound closure technique and acute wound complications in gastric surgery for morbid obesity: A prospective randomized trial. J Am Coll Surg 2000;191:238-43.
61. Culver DH, Horan TC, Gaynes RP, et al. Surgical wound infection rates by wound class, operative procedure and patient risk index: National Nosocomial Infections Surveillance System. Am J Med 1991;91(Suppl):152-7.
62. Monteforte MJ, Turkelson CM. Bariatric surgery for morbid obesity. Obes Surg 2000;10:391-401.
63. Kellum JM, DeMaria EJ, Sugerman HJ. The surgical treatment of morbid obesity. Curr Probl Surg 1998;35:791-858.
64. Pories WJ, Swanson MS, McDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-50.
65. Fisher A, Waterhouse TD, Adams AP. Obesity: Its relation to anaesthesia. Anaesthesia 1975;30:633-47.
66. Blaszyk H, Wollan PC, Witkiewicz AK, Björnsson J. Death from pulmonary thromboembolism in severe obesity: Lack of association with established genetic and clinical risk factors. Virchows Arch 1999;434:529-32.
67. Blaszyk H, Björnsson J. Factor V Leiden and morbid obesity in fatal postoperative pulmonary embolism. Arch Surg 2000;135:1410-3.
68. Kakkar VV, Howe CT, Nicolaides AN, et al. Deep vein thrombosis of the leg: Is there a "high risk" group? Ann Surg 1970; 120:527-32.
69. Pineo GF, Hull RD. Unfractionated and low-molecular weight heparin: Comparison and current recommendations. Med Clin North Am 1998;82:587-99.
70. Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 2002;12:19-24.
71. Kalfarentzos F, Stavropoulou F, Yarmenitis S, et al. Prophylaxis of venous thromboembolism using two different doses of low-molecular weight heparin (nadroparin) in bariatric surgery: A prospective randomized trial. Obes Surg 2001;11:670-6.
72. Bergquist D, Eldor A, Thorlacius-Ussing O, et al. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicenter trial with venographic assessment. Br J Surg 1997;84:1099-103.
73. Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg 2000; 10:7-13.
74. Olympic Vac-Pac®: Current Sales and Instruction Manual. Seattle, WA: Olympic Medical, 2002.
75. Jupiter JB, Ring D, Rosen H. The complications and difficulties of nonunion in the severely obese. J Orthop Trauma 1995;9:363-70.
76. Sawyer RJ, Richmond MN, Hickey JD, Jarratt JA. Peripheral nerve injuries associated with anaesthesia. Anaesthesia 2000; 55:980-91.
77. Warner MA, Warner ME, Martin JT. Ulnar neuropathy: Incidence, outcome, and risk factors in sedated or anesthetized patients. Anesthesiology 1994;81:1332-40.
78. Coşkun F. Anesthesia for gynecologic laparoscopy. J Am Assoc Gynecol Laparosc 1999;6:245-58.
79. Chui PT, Gin T, Oh TE. Anaesthesia for laparoscopic surgery. Anaesth Intensive Care 1993;21:163-71.
80. Kashtan J, Green JF, Parsons EQ, Holcroft JW. Hemodynamic effects of increased abdominal pressure. J Surg Res 1981;30:249-55.
81. Harman PK, Kron IL, McLachlan HD, et al. Elevated intraabdominal pressure and renal function. Ann Surg 1982;196:594-7.
82. Rosen DM, Chou DC, North L, et al. Femoral venous blood flow during laparoscopic gynecologic surgery. Surg Laparosc Endosc Percutan Tech 2000;10:158-62.
83. Cunningham AJ, Brull SJ. Laparoscopic cholecystectomy: Anesthetic implications. Anesth Analg 1993;76:1120-33.
84. Sprung J, Whalley DG, Falcone T, et al. The impact of morbid obesity, pneumoperitoneum, and posture on respiratory system mechanics and oxygenation during laparoscopy. Anesth Analg 2002;94:1345-50.
85. Maxwell MH, Waks AU, Schroth PC, et al. Error in blood pressure measurement due to incorrect cuff size in obese patients. Lancet 1982;2:33-6.
86. Mann GV. The influence of obesity on health. N Engl J Med 1974;291:178-85, 226-32.
87. Emerick DR. An evaluation of non-invasive blood pressure (NIBP) monitoring on the wrist: Comparison with upper arm NIBP measurement. Anaesth Intensive Care 2002;30:43-7.
88. Block FE, Schulte GT. Ankle blood pressure measurement, an acceptable alternative to arm measurements. Int J Clin Monit Comput 1996;13:167-71.
89. McCarroll SM, Saunders PR, Brass PJ. Anesthetic considerations in obese patients. Prog Anesthesiol 1989;3:1-12.
90. Brodsky JB, Lemmens HJM, Brock-Utne JG, et al. Morbid obesity and tracheal intubation. Anesth Analg 2002;94:732-6.
91. Jung D, Mayersohn M, Perrier D, et al. Thiopental disposition in lean and obese patients undergoing surgery. Anesthesiology 1982;56:269-74.
92. Servin F, Farinotti R, Haberer JP, et al. Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide: A clinical and pharmacokinetic study. Anesthesiology 1993;78:657-65.
93. Adams JP, Murphy PG. Obesity in anaesthesia and intensive care. Br J Anaesth 2000;85:91-108.
94. Greenblatt DJ, Abernethy DR, Locniskar A, et al. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984;62:27-35.
95. Schwartz AE, Matteo RS, Ornstein E, et al. Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient. Anesth Analg 1992;74:515-8.
96. Puhringer FK, Khuenl-Brady KS, Mitterschiffthaler G. Rocuronium bromide: Time-course of action in underweight, normal weight, overweight, and obese patients. Eur J Anaesthesiol 1995;11(Suppl):107-10.
97. Puhringer FK, Keller C, Kleinsasser A, et al. Pharmacokinetics of rocuronium bromide in obese female patients. Eur J Anaesthesiol 1999;16:507-10.
98. Weinstein JA, Matteo RS, Ornstein E, et al. Pharmacodynamics of vecuronium and atracurium in the obese surgical patient. Anesth Analg 1988;67:1149-53.
99. Varin F, Ducharme J, Theoret Y, et al. Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium. Clin Pharmacol Ther 1990;48:18-25.
100. Schwartz AE, Matteo RS, Ornstein E, et al. Pharmacokinetics of sufentanil in obese patients. Anesth Analg 1991;73:790-3.
101. Egan TD, Huizinga B, Gupta SK, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998; 89:562-73.
102. Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology 1997;86:24-33.
103. Blouin RA, Warren GW. Pharmacokinetic considerations in obesity. J Pharm Sci 1999;88:1-7.
104. Abernethy DR, Greenblatt DJ, Divoll M, Shader RI. Prolonged accumulation of diazepam in obesity. J Clin Pharmacol 1983; 23:369-76.
105. Abernethy DR, Greenblatt DJ, Smith TW. Digoxin disposition in obesity: Clinical pharmacokinetic investigation. Am Heart J 1981;102:740-4.
106. Christoff PB, Conti DR, Naylor C, Jusko WJ. Procainamide disposition in obesity. Drug Intell Clin Pharm 1983;17:516-22.
107. Deleted in proof.
108. Juvin P, Vadam C, Malek L, et al. Postoperative recovery after desflurane, propofol, or isoflurane anesthesia among morbidly obese patients: A prospective randomized study. Anesth Analg 2000;91:714-9.
109. Sollazzi L, Perilli V, Modesti C, et al. Volatile anesthesia in bariatric surgery. Obes Surg 2001;11:623-6.
110. Torri G, Casati A, Albertin A, et al. Randomized comparison of isoflurane and sevoflurane for laparoscopic gastric banding in morbidly obese patients. J Clin Anesth 2001;13:565-70.
111. Luce MJ. Respiratory complications of obesity. Chest 1980;78:626-31.
112. De Divitiis O, Fazio S, Pettito M, Petitto M. Obesity and cardiac function. Circulation 1981;64;477-82.
113. Rexrode KM, Manson JE, Hennekens CH. Obesity and cardiovascular disease. Curr Opin Cardiol 1996;11:490-5.
114. Buckley FP, Robinson NB, Simonowitz DA. Anaesthesia in the morbidly obese: A comparison of anaesthetic and analgesic regimens for upper abdominal surgery Anaesthesia 1983;38:840-51.
115. Nguyen NT, Lee SL, Goldman C, et al. Comparison of pulmonary function and postoperative pain after laparoscopic versus open gastric bypass: A randomized trial. J Am Coll Surg 2001; 192:469-76.
116. Michaloudis D, Fraidakis O, Petrou A, et al. Continuous spinal anesthesia/analgesia for perioperative management of morbidly obese patients undergoing laparotomy for gastroplastic surgery. Obes Surg 2000;10:220-9.
117. Cooper JR, Brodsky JB. Anesthetic management of the morbidly obese patient. Semin Anesth 1987;6:260-70.
118. Bardoczky GI, Yernault JC, Houben JJ, d'Hollander AA. Large tidal volume ventilation does not improve oxygenation in morbidly obese patients during anesthesia. Anesth Analg 1995;81:385-8.
119. Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema: Respective effects of high airway pressure, high tidal volume and positive end-expiratory pressure. Am Rev Respir Dis 1988;137:1159-64.
120. Söderberg M, Thomson D, White T. Respiration, circulation, and anesthetic management in obesity: Investigation before and after jejuno-ileal bypass. Acta Anaesthesiol Scand 1977;21:55-61.
121. Øberg B, Poulsen TD. Obesity: An anesthetic challenge. Acta Anaesthesiol Scand 1996;40:191-200.
122. Sugerman HJ. Pulmonary, function in morbid obesity. Gastroenterol Clin North Am 1987;16:225-37.
123. Schafer H, Ewig S, Hasper E, Luderitz B. Failure of CPAP therapy in obstructive sleep apnea syndrome: Predictive factors and treatment with bilevel-positive airway pressure. Respir Med 1998;92:208-15.
124. Joris JL, Sottiaux TM, Chiche JD, et al. Effect of bi-level positive airway pressure (BiPAP) nasal ventilation on the postoperative pulmonary restrictive syndrome in obese patients undergoing gastroplasty. Chest 1997;111:665-70.
125. Huerta S, DeShields S, Shpiner R, et al. Safety and efficacy of postoperative continuous positive airway pressure to prevent pulmonary complications after Roux-en-Y gastric bypass. J Gastrointest Surg 2002;6:354-8.
126. Yao F-SF, Savarese JJ. Morbid obesity. In: Yao F-SF, ed. Anesthesiology: Problem Oriented Patient Management. Philadelphia: Lippincott-Raven, 1998:1001-18.
127. Byrne TK. Complications of surgery for obesity. Surg Clin North Am 2001;81:1181-93.
128. Overend TJ, Anderson CM, Lucy SD, et al. The effect of incentive spirometry on postoperative pulmonary complications: A systematic review. Chest 2001;120:971-8.
129. Celli BR, Rodriguez KS, Snider GL. A controlled trial of intermittent positive pressure breathing, incentive spirometry, and deep breathing exercises in preventing pulmonary complications after abdominal surgery. Am Rev Respir Dis 1984;130:12-5.
130. Fox GS, Whalley DG, Bevan OR. Anaesthesia for the morbidly obese: Experience with 110 patients. Br J Anaesth 1981;53:811-6.
131. Rawal N, Sjöstrand LJ, Christofferson E, et al. Comparison of intramuscular and epidural morphine for postoperative analgesia in the grossly obese: Influence on postoperative ambulation and pulmonary function. Anesth Analg 1984;63:583-92.
132. Gelman S, Laws BL, Potzick J, et al. Thoracic epidural vs. balanced anesthesia in morbid obesity: An intraoperative and postoperative hemodynamic study. Anesth Analg 1980;59:902-8.
133. Otsu I, Thirlby RC, Allen HW. Patient controlled thoracic epidural analgesia after gastric bypass surgery for morbid obesity [abstract]. Reg Anesth Pain Med 2001;26:A117.
134. Carli F, Trudel JL, Belliveau P. The effect of intraoperative thoracic epidural anesthesia and postoperative analgesia on bowel function after colorectal surgery: A prospective, randomized trial. Dis Colon Rectum 2001;44:1083-9.
135. Goulding ST, Hovell BC. Anesthetic experience with vertical banded gastroplasty. Br J Anaesth 1995;75:301-6.
136. Choi YK, Brolin RE, Wagner BK, et al. Efficacy and safety of patient-controlled analgesia for morbidly obese patients following gastric bypass surgery. Obes Surg 2000;10:154-9.
137. IBSR 2000-2001 winter pooled report. Iowa City: International Bariatric Surgery Registry, 2001:7-15.